Chris Calcaterra

Chris Calcaterra

Chief Operating Officer, Glaukos

Mr. Calcaterra has served as the chief operating officer for Glaukos Corporation since February 2017. He was previously the chief commercial officer, a position he had held since joining Glaukos in April 2008. Mr. Calcaterra has more than 30 years of experience in the ophthalmic medical technology industry. Prior to joining Glaukos, Mr. Calcaterra was senior vice president at Advanced Medical Optics, Inc. (acquired by Abbott Laboratories), and was responsible for its cataract business. Prior to that position, Mr. Calcaterra held increasingly responsible vice president positions in a variety of sales and marketing roles at Advanced Medical Optics, Inc., as well as its predecessor surgical division business at Allergan, Inc. Mr. Calcaterra has a B.S. from Miami University and an M.B.A. from Xavier University, and he was previously a board member of WaveTec Vision Systems, Inc. (acquired by Novartis)